News

WADA PUBLISHES THE TECHNICAL DOCUMENTS TD2017CG/LH, TD2017MRPL, TD2017DL (VERSION 2) AND TD2017NA

May 24, 2017

Following approval by the World Anti-Doping Agency's (WADA's) Executive Committee on 17 May 2017, WADA announces the publication of the following Technical Documents: 
 
TD2017CG/LH - Reporting and Management of Urinary Huma Chorionic Ganadotropin (hCG) and Luteinizing Hormone (LH) Finidings in Male Athletes along with the Summary of Modification.


This Technical Document replaces the current Guidelines on Reporting and Management of Urinary hCG and LH Findings in Male Athletes. It provides important changes and clarifications regarding acceptance values of assay performance for the newly introduced LC-MS/MS assay and the correction of Decision Limit depending on the specific gravity.


TD2017MRPL - Minimum Required Performace Levels for Detection and Identification of Non-Threshold Substances along with the Summary of Modifications.

This Technical Document is an update of the current Technical Document TD2015MRPL. It includes the addition of minimum required performance levels (MRPL) for new categories of substances as well as specific instructions on the reporting of some non-threshold substances.
 
TD2017DL version 2 - Decision Limits for the Confirmatory Quantification of Threshold Substances along with the Summary of Modifications.

This Technical Document is an update of  the current Technical Document TD2017DL  version 1. It includes important changes and clarifications on compliance decisions for quantification procedures and reflects changes made in other WADA Technical Documents (TD2017NA, TD2017CG/LH).

TD2017NA-Harmonization of Analysis and Reporting of 19-Norsteroids Related to Nandrolone along with the Summary of Modifications.
 
This Technical Document is an update of the current Technical Document TD2016NA. It includes important changes including the elimination of the need for a 19-NA quantification procedure and emphasizing the application of IRMS analysis to determine the origin of low concentrations of 19-NA in urine samples.

All WADA accredited Laboratories are required to implement these Technical Documents in their procedures by 1 September 2017.


Source wada news release